A: This product is formulated for intravenous (IV), intramuscular (IM), subcutaneous (SC), and intradermal (ID) administration routes
Oral semaglutide at $289/mo (or $249/mo on the 6-month plan) provides an alternative if injection side effects persist, though oral formulations are absorbed differently and may trigger different digestive responses in some patients
Hospital Variation in Intravenous Inotrope Use for Patients Hospitalized With Heart Failure
Additionally, the LEADER study reported a post-hoc analysis in patients with polyvascular disease (defined as atherosclerosis in two or more of the following vasculature territories: ocular, coronary arteries, cerebral arteries or arteries peripheral), in which they did not observe significant differences in the risk of non-fatal stroke in the liraglutide group versus placebo [63]
Sen S et al.: Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia